MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
<AdverseEvent xmlns="http://hl7.org/fhir">
<id value="mii-exa-onko-oxaliplatin-neuropathy"/>
<language value="de"/>
<text>
<status value="generated"/>
<div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: AdverseEvent mii-exa-onko-oxaliplatin-neuropathy</b></p><a name="de-mii-exa-onko-oxaliplatin-neuropathy"> </a><a name="de-hcmii-exa-onko-oxaliplatin-neuropathy"> </a><p><b>actuality</b>: Adverse Event</p><p><b>event</b>: <span title="Codes:{https://www.meddra.org 10034620}">Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)</span></p><p><b>subject</b>: <a href="Patient-example-modification.html">Martin Beispiel Male, DoB: 1958-11-03</a></p><p><b>date</b>: 2024-06-10</p><p><b>detected</b>: 2024-06-05</p><p><b>recordedDate</b>: 2024-06-10</p><p><b>seriousness</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/adverse-event-seriousness non-serious}">Non-serious</span></p><p><b>severity</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/adverse-event-severity severe}">Severe</span></p><blockquote><p><b>suspectEntity</b></p><p><b>instance</b>: <a href="MedicationStatement-mii-exa-onko-modification-oxaliplatin-phase1.html">MedicationStatement: status = stopped; statusReason = Adverse reaction (disorder); medication[x] = Oxaliplatin; effective[x] = 2024-03-15 --> 2024-06-10; note = FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.</a></p><h3>Causalities</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Assessment</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess certain}">Certain</span></td></tr></table></blockquote></div>
</text>
<actuality value="actual"/>
<event>
<coding>
<system value="https://www.meddra.org"/>
<code value="10034620"/>
<display value="Peripheral sensory neuropathy"/>
</coding>
<text
value="Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)"/>
</event>
<subject>🔗
<reference value="Patient/example-modification"/>
</subject>
<date value="2024-06-10"/>
<detected value="2024-06-05"/>
<recordedDate value="2024-06-10"/>
<seriousness>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/adverse-event-seriousness"/>
<code value="non-serious"/>
</coding>
</seriousness>
<severity>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/adverse-event-severity"/>
<code value="severe"/>
<display value="Severe"/>
</coding>
</severity>
<suspectEntity>
<instance>🔗
<reference
value="MedicationStatement/mii-exa-onko-modification-oxaliplatin-phase1"/>
</instance>
<causality>
<assessment>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess"/>
<code value="certain"/>
<display value="Certain"/>
</coding>
</assessment>
</causality>
</suspectEntity>
</AdverseEvent>